Rapid RV/LV vs Eko Low Ejection Fraction Tool (ELEFT)
AI Verdict
Choose Rapid RV/LV if…
Choose Rapid RV/LV if your clinical workflow requires rapid, AI-powered assessment of pulmonary embolism severity directly from CTPA scans. This tool is ideal for emergency departments and critical care settings where quick, objective measurement of RV/LV ratios is crucial for triaging patients and guiding immediate treatment decisions for suspected PE.
View Rapid RV/LV →Choose Eko Low Ejection Fraction Tool (ELEFT) if…
Choose Eko Low Ejection Fraction Tool (ELEFT) if you need a non-invasive, point-of-care screening tool for early detection of low ejection fraction during routine physical exams. This solution is best suited for primary care and general cardiology practices looking to proactively identify patients at risk for heart failure using integrated digital stethoscope technology.
View Eko Low Ejection Fraction Tool (ELEFT) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Rapid RV/LV | Eko Low Ejection Fraction Tool (ELEFT) |
|---|---|---|
| Pricing | Contact vendor for pricing information. | Unknown |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Low Ejection Fraction Tool (ELEFT)ELEFT integrates seamlessly into a routine physical exam using a familiar tool (stethoscope) and provides near real-time results (15 seconds), making it highly accessible and easy to adopt for a wide range of clinicians at the point of care. Rapid RV/LV, while efficient for imaging specialists, requires a CTPA scan and is integrated into a more specialized radiology workflow.
Clinical Value
TieBoth tools are FDA-cleared and address critical clinical needs with significant impact. Rapid RV/LV provides crucial, time-sensitive severity assessment for acute pulmonary embolism, directly influencing immediate treatment. ELEFT offers early, non-invasive detection of heart failure risk during routine exams, enabling proactive management and potentially preventing disease progression. Their clinical value is high and distinct in their respective applications.
Pricing & Value
TieBoth tools lack transparent public pricing, requiring direct contact with the vendor for details. Without specific pricing structures, licensing models, or publicly available ROI studies, it is impossible to conduct a meaningful head-to-head comparison of their financial value.
Enterprise Readiness
Rapid RV/LVRapid RV/LV offers more flexible deployment options (on-premises or hybrid), which can be critical for diverse enterprise environments with varying IT infrastructure and data governance requirements. Its integration into a broader Rapid platform with existing triage and notification capabilities also suggests a more mature and comprehensive enterprise solution.
Innovation
Eko Low Ejection Fraction Tool (ELEFT)ELEFT demonstrates greater innovation by integrating AI directly into a widely used, non-invasive diagnostic tool (digital stethoscope) for real-time screening at the point of care. This approach democratizes advanced cardiac assessment and brings sophisticated AI capabilities into routine physical examinations in a novel way.
Support & Docs
Rapid RV/LVRapidAI provides comprehensive 24/7/365 customer support via multiple channels (email, phone with international numbers) and a robust library of educational resources including clinical and technical FAQs, guides, videos, and webinars. While Eko Health offers various support options and documentation, some user feedback indicates potential inconsistencies in support responsiveness.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Rapid RV/LV | Eko Low Ejection Fraction Tool (ELEFT) |
|---|---|---|
| Tool Name | Rapid RV/LV | Eko Low Ejection Fraction Tool (ELEFT) |
| Company | RapidAI (formerly iSchemaView) | Eko Health |
| Primary Purpose | Rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans. | Aids clinicians in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams. |
| Primary Input Data | CTPA images | ECG and heart sound recordings |
| Key Measurement/Output | Automated measurement of right and left ventricle diameters; Calculation of RV/LV ratio | AI-powered low ejection fraction detection |
| Result Speed | Within minutes of scan | Approximately 15 seconds |
| Integration | Integration with Rapid PE solution | Integrates with FDA-cleared Eko digital stethoscopes; Part of the SENSORAu2122 Cardiac Early Detection Platform |
| Target Condition | Pulmonary embolism severity | Low ejection fraction, a key indicator of heart failure |
Videos
Demos, reviews, and walkthroughs featuring Rapid RV/LV and Eko Low Ejection Fraction Tool (ELEFT).
Frequently Asked Questions
More Comparisons
More matchups featuring Rapid RV/LV or Eko Low Ejection Fraction Tool (ELEFT)
Backers
Who funded each tool's parent company.